09.01.08
WellGen, Inc., New Brunswick, NJ, has been awarded U.S. Patent No.7,238,376, titled “Black Tea Extract for Prevention of Disease,” which covers, among other things, its proprietary product, WG0401, an enriched extract from black tea that has demonstrated inflammation-fighting properties. The patent covers the uses of WG0401 for arthritis, inflammation and cancer.